Dr Kieran Mullan

It is a pleasure to serve under your chairship, Ms Lewell. I will keep my remarks brief because the debate is so well attended. It is a real privilege to speak in this debate on behalf of so many people in my constituency who have campaigned tirelessly to improve care and support for those living with Parkinson’s. Parkinson’s UK tells me that in Bexhill and Battle, around 377 people live with Parkinson’s. I pay special tribute to my constituents Linda, Helen and Vivienne, who join us in the Public Gallery today. They are part of a fantastic local Parkinson’s group, which campaigns with energy, determination and an unwavering commitment to the community, and their advocacy has brought the realities of living with Parkinson’s to the forefront, highlighting not just the challenges but practical solutions. Their work has also been key in raising awareness locally around the Parky charter petition. I am immensely proud that Bexhill and Battle recorded 576 signatures, the highest number anywhere in the UK. That is a testament to the strength of feeling in our area and the dedication of campaigners who ensured every voice was heard. The charter aims to highlight delays in diagnosis, fragmented care, failed benefits assessments and underinvestment in research as key areas where we need to do better. Delays in diagnosis can have irreversible consequences. Around 21,000 people in the UK currently live with Parkinson’s undiagnosed. Access to a full multidisciplinary team is another central pillar of good care, yet only 44% of people have access to an occupational therapist; 62% to a physiotherapist; and 40% to a speech and language therapist. Research is needed to create a brighter future for Parkinson’s sufferers. Currently, there is no cure and treatment options are limited. With someone diagnosed every 20 minutes in the UK and 25 million people affected globally, the need for new therapies is urgent. Closer to home, we have seen some encouraging steps in local Parkinson’s services. Our local trust has signed up to Parkinson’s Connect, allowing direct referral at the point of diagnosis. The trust now supports around 800 patients and the specialist team has grown from one to four staff members over the past two years. Home visits and outreach clinics are planned, which could make a meaningful difference once fully operational, but progress remains uneven.